Skip to content

Observation of the effect of ultrasound-guided continuous thoracic paravertebral block on the long-term prognosis of patients with herpes zoster-associated neuralgia and its influencing factors

Observation of the effect of ultrasound-guided continuous thoracic paravertebral block on the long-term prognosis of patients with herpes zoster-associated neuralgia and its influencing factors

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089533
Enrollment
Unknown
Registered
2024-09-10
Start date
2024-09-12
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster-associated neuralgia

Interventions

Continuous thoracic paravertebral block group (Group I):None
Oral medication group (Group C):None

Sponsors

Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with herpes zoster-related neuralgia in the thoracic dorsum and lumbar abdomen admitted to our hospital during 2021.01.01-2023.12.31 (including herpes zoster neuralgia; herpes zoster subacute pain and herpes zoster postherpetic neuralgia patients) were included according to the inclusion criteria; no other interventional treatments were performed except for ultrasound-guided consecutive thoracic paravertebral blocks for patients in the nerve block group (including pulsed radiofrequency, nerve disruption, epidural/intrathecal drug channel implantation, spinal cord electrical stimulation, etc.); at the time of consultation, NRS score > 3 or more; consecutive thoracic paravertebral block = 3 times or more

Exclusion criteria

Exclusion criteria: At the time of consultation, NRS score <3; patients with herpes at other sites; patients without consecutive thoracic paravertebral blocks (<3); patients with comorbid severe cardiac, hepatic, and renal insufficiency; patients with comorbid psychiatric disorders who are unable to understand or cooperate with the patient

Design outcomes

Primary

MeasureTime frame
Time required for patient symptoms to improve significantly (no oral pain medication and NRS<3);

Countries

China

Contacts

Public ContactWang Qian

Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University

1551817590@qq.com+86 199 6204 2718

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026